170 related articles for article (PubMed ID: 12453601)
1. Oxidative stress and disturbed glutamate transport in spinal muscular atrophy.
Hayashi M; Araki S; Arai N; Kumada S; Itoh M; Tamagawa K; Oda M; Morimatsu Y
Brain Dev; 2002 Dec; 24(8):770-5. PubMed ID: 12453601
[TBL] [Abstract][Full Text] [Related]
2. Neuropathological analysis in spinal muscular atrophy type II.
Araki S; Hayashi M; Tamagawa K; Saito M; Kato S; Komori T; Sakakihara Y; Mizutani T; Oda M
Acta Neuropathol; 2003 Nov; 106(5):441-8. PubMed ID: 12898156
[TBL] [Abstract][Full Text] [Related]
3. GLT-1 glutamate transporter levels are unchanged in mice expressing G93A human mutant SOD1.
Deitch JS; Alexander GM; Del Valle L; Heiman-Patterson TD
J Neurol Sci; 2002 Jan; 193(2):117-26. PubMed ID: 11790392
[TBL] [Abstract][Full Text] [Related]
4. Glutamate transporters in the spinal cord of the wobbler mouse.
Bigini P; Bastone A; Mennini T
Neuroreport; 2001 Jul; 12(9):1815-20. PubMed ID: 11435904
[TBL] [Abstract][Full Text] [Related]
5. The expression of the glutamate re-uptake transporter excitatory amino acid transporter 1 (EAAT1) in the normal human CNS and in motor neurone disease: an immunohistochemical study.
Banner SJ; Fray AE; Ince PG; Steward M; Cookson MR; Shaw PJ
Neuroscience; 2002; 109(1):27-44. PubMed ID: 11784698
[TBL] [Abstract][Full Text] [Related]
6. Oxidative stress and disturbed glutamate transport in hereditary nucleotide repair disorders.
Hayashi M; Itoh M; Araki S; Kumada S; Shioda K; Tamagawa K; Mizutani T; Morimatsu Y; Minagawa M; Oda M
J Neuropathol Exp Neurol; 2001 Apr; 60(4):350-6. PubMed ID: 11305870
[TBL] [Abstract][Full Text] [Related]
7. Motor neuron mitochondrial dysfunction in spinal muscular atrophy.
Miller N; Shi H; Zelikovich AS; Ma YC
Hum Mol Genet; 2016 Aug; 25(16):3395-3406. PubMed ID: 27488123
[TBL] [Abstract][Full Text] [Related]
8. Transgenic SOD1 G93A mice develop reduced GLT-1 in spinal cord without alterations in cerebrospinal fluid glutamate levels.
Bendotti C; Tortarolo M; Suchak SK; Calvaresi N; Carvelli L; Bastone A; Rizzi M; Rattray M; Mennini T
J Neurochem; 2001 Nov; 79(4):737-46. PubMed ID: 11723166
[TBL] [Abstract][Full Text] [Related]
9. Spinal cord-specific deletion of the glutamate transporter GLT1 causes motor neuron death in mice.
Sugiyama K; Tanaka K
Biochem Biophys Res Commun; 2018 Mar; 497(2):689-693. PubMed ID: 29458024
[TBL] [Abstract][Full Text] [Related]
10. Increased internalisation and degradation of GLT-1 glial glutamate transporter in a cell model for familial amyotrophic lateral sclerosis (ALS).
Vanoni C; Massari S; Losa M; Carrega P; Perego C; Conforti L; Pietrini G
J Cell Sci; 2004 Oct; 117(Pt 22):5417-26. PubMed ID: 15466883
[TBL] [Abstract][Full Text] [Related]
11. Decrease in glial glutamate transporter variants and excitatory amino acid receptor down-regulation in a murine model of ALS-PDC.
Wilson JM; Khabazian I; Pow DV; Craig UK; Shaw CA
Neuromolecular Med; 2003; 3(2):105-18. PubMed ID: 12728193
[TBL] [Abstract][Full Text] [Related]
12. SMN deficiency does not induce oxidative stress in SMA iPSC-derived astrocytes or motor neurons.
Patitucci TN; Ebert AD
Hum Mol Genet; 2016 Feb; 25(3):514-23. PubMed ID: 26643950
[TBL] [Abstract][Full Text] [Related]
13. Nonoxidative protein glycation is implicated in familial amyotrophic lateral sclerosis with superoxide dismutase-1 mutation.
Shibata N; Nagai R; Miyata S; Jono T; Horiuchi S; Hirano A; Kato S; Sasaki S; Asayama K; Kobayashi M
Acta Neuropathol; 2000 Sep; 100(3):275-84. PubMed ID: 10965797
[TBL] [Abstract][Full Text] [Related]
14. Glial restricted precursors protect against chronic glutamate neurotoxicity of motor neurons in vitro.
Maragakis NJ; Rao MS; Llado J; Wong V; Xue H; Pardo A; Herring J; Kerr D; Coccia C; Rothstein JD
Glia; 2005 Apr; 50(2):145-59. PubMed ID: 15657939
[TBL] [Abstract][Full Text] [Related]
15. Spinal cord GLT-1 glutamate transporter and blood glutamic acid alterations in motor neuron degeneration (Mnd) mice.
Mennini T; Bastone A; Crespi D; Comoletti D; Manzoni C
J Neurol Sci; 1998 Apr; 157(1):31-6. PubMed ID: 9600674
[TBL] [Abstract][Full Text] [Related]
16. Differential involvement of vesicular and glial glutamate transporters around spinal α-motoneurons in the pathogenesis of SOD1
Ohgomori T; Yamasaki R; Takeuchi H; Kadomatsu K; Kira JI; Jinno S
Neuroscience; 2017 Jul; 356():114-124. PubMed ID: 28526579
[TBL] [Abstract][Full Text] [Related]
17. Expressions of nitrotyrosine and TUNEL immunoreactivities in cultured rat spinal cord neurons after exposure to glutamate, nitric oxide, or peroxynitrite.
Manabe Y; Wang JM; Murakami T; Warita H; Hayashi T; Shoji M; Abe K
J Neurosci Res; 2001 Sep; 65(5):371-7. PubMed ID: 11536319
[TBL] [Abstract][Full Text] [Related]
18. Edaravone is a candidate agent for spinal muscular atrophy: In vitro analysis using a human induced pluripotent stem cells-derived disease model.
Ando S; Funato M; Ohuchi K; Kameyama T; Inagaki S; Seki J; Kawase C; Tsuruma K; Shimazawa M; Kaneko H; Hara H
Eur J Pharmacol; 2017 Nov; 814():161-168. PubMed ID: 28826912
[TBL] [Abstract][Full Text] [Related]
19. Increased expression of the glial glutamate transporter EAAT2 modulates excitotoxicity and delays the onset but not the outcome of ALS in mice.
Guo H; Lai L; Butchbach ME; Stockinger MP; Shan X; Bishop GA; Lin CL
Hum Mol Genet; 2003 Oct; 12(19):2519-32. PubMed ID: 12915461
[TBL] [Abstract][Full Text] [Related]
20. Excitatory amino acid transporter 1 and 2 immunoreactivity in the spinal cord in amyotrophic lateral sclerosis.
Sasaki S; Komori T; Iwata M
Acta Neuropathol; 2000 Aug; 100(2):138-44. PubMed ID: 10963360
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
